Natco Pharma Ltd. (NATCOPHARM)
Market Closed
8 Dec, 10:00
XNSE XNSE Primary MSE ₹
897. 75
-35.85
-3.84%
₹
178.38B Market Cap
13.93 P/E Ratio
5% Div Yield
1,121,602 Volume
0 Eps
₹ 933.6
Previous Close Day Range
892.35 945.7
Year Range
726.8 1,505
Want to track NATCOPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 64 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| NATCOPHARM Natco Pharma Ltd. 12 Feb 2026 (In 2 months) | | 5.7 | - |
| NATCOPHARM Natco Pharma Ltd. 10 Feb 2026 (In 2 months) | | - | - |
| NATCOPHARM Natco Pharma Ltd. 14 Nov 2025 | | 24.56 | 28.94 |
| NATCOPHARM Natco Pharma Ltd. 13 Nov 2025 | | 24.56 | - |
| NATCOPHARM Natco Pharma Ltd. 11 Nov 2025 | | 24.56 | - |
| NATCOPHARM Natco Pharma Ltd. 10 Nov 2025 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 11 Aug 2025 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 12 Feb 2025 | | 13.36 | 7.43 |
| NATCOPHARM Natco Pharma Ltd. 12 Nov 2024 | | 31.5 | 37.81 |
| NATCOPHARM Natco Pharma Ltd. 27 Sep 2024 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 7 Aug 2024 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 27 May 2024 | | 16.01 | 21.56 |
| NATCOPHARM Natco Pharma Ltd. 7 Feb 2024 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 8 Nov 2023 | | - | - |
| NATCOPHARM Natco Pharma Ltd. 11 Nov 2016 | | 1.87 | 3.8 |
| NATCOPHARM Natco Pharma Ltd. 10 Feb 2014 | | 3.44 | 10.12 |
| NATCOPHARM Natco Pharma Ltd. 14 Nov 2013 | | 9.3 | 9.34 |
NATCOPHARM Earnings Reports FAQ
What is the earnings per share (EPS) for NATCOPHARM?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 9.88%, reflecting the NATCOPHARM's performance and XNSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-10, based on the NATCOPHARM's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 28.94 per share, reported on 2025-11-14. For dividend history, visit the NATCOPHARM Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 31.02, calculated based on the most recent stock price of ₹897.75.
2025 © Marketlog. All Rights Reserved.
